Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Legislation to regulate medical devices.

M Harris

    Biomaterials, Medical Devices, and Artificial Organs
    |January 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    The history of medical device regulation evolved to ensure safety and efficacy. Early laws focused on marketing, but technological advancements necessitated stricter premarket review and performance standards for medical devices.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Physical and functional interaction of Nef with Lck. HIV-1 Nef-induced T-cell signaling defects.

    The Journal of biological chemistry·1996
    Same author

    Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1996
    Same author

    TAP associates with a unique class I conformation, whereas calnexin associates with multiple class I forms in mouse and man.

    Journal of immunology (Baltimore, Md. : 1950)·1995
    Same author

    Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation.

    Journal of neurochemistry·1995
    Same author

    Episodically homeless women with serious mental illness: prevalence of physical and sexual assault.

    The American journal of orthopsychiatry·1995
    Same author

    Autologous blood stem cell transplantation for haematological malignancy: treatment-related mortality of 2%.

    Australian and New Zealand journal of medicine·1995
    Same journal

    Custom-made vaginal balloons for strengthening circumvaginal musculature.

    Biomaterials, medical devices, and artificial organs·1986
    Same journal

    Osteogenesis induced by bone matrix is inhibited by inflammation.

    Biomaterials, medical devices, and artificial organs·1986
    Same journal

    Electronic antihemocoagulation.

    Biomaterials, medical devices, and artificial organs·1986
    Same journal

    Bone remodeling associated with a flexible femoral intramedullary implant.

    Biomaterials, medical devices, and artificial organs·1986
    Same journal

    The effect of post-sintering heat treatments on the tensile properties of Ti-6A1-4V alloy.

    Biomaterials, medical devices, and artificial organs·1986
    Same journal

    Electrical conduction in bone in frequency range 0.4-1.3 GHz.

    Biomaterials, medical devices, and artificial organs·1986
    See all related articles

    Area of Science:

    • Medical Device Regulation
    • Public Health Policy
    • Health Law

    Background:

    • The need for medical device regulation emerged from harmful or ineffective products.
    • Post-WWII technological advancements increased the complexity and risk associated with medical devices.
    • Existing regulations under the Food, Drug, and Cosmetic Act (1938) were insufficient.

    Purpose of the Study:

    • To trace the historical development of medical device regulation.
    • To identify key legislative milestones and their impact.
    • To highlight the evolving requirements for medical device safety and performance.

    Main Methods:

    • Historical analysis of legislative actions and commission reports.
    • Review of amendments to the Food, Drug, and Cosmetic Act.

    Related Experiment Videos

  • Examination of the legislative process for the Medical Device Amendments of 1973/1975.

    • Main Results:

    • Initial FDA authority (1938) was limited to post-market surveillance of labeling and advertising.
    • A 1969 HEW commission report recommended a risk-based classification system for devices.
    • The Medical Device Amendments, proposed in 1973, aimed to implement premarket review and standards, eventually passing in 1975.

    Conclusions:

    • The evolution of medical device regulation reflects a growing understanding of technological risks.
    • Legislation has progressively shifted towards proactive safety and performance evaluation.
    • The establishment of a tiered regulatory framework is crucial for public health protection.